ESRX 79.50 Express Scripts $ESRX Hit a 52 week high of

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
ESRX 79.50 Express Scripts $ESRX Hit a 52 week high of 79.53 Closing the day 09:45 at 79.50 +0.03 +0.04% With a day low of 79.07 and a total volume of 315,777.

ESRX Recent Posts: http://investorshangout.com/Express-Scripts-H...SRX-54047/

ESRX Express Scripts Recent Headline News

Jim Cramer's 'Mad Money' Recap: How You Can Profit From My Mistakes
at The Street - Wed Nov 19, 6:00PM CST
Even Cramer gets them wrong once in a while and he wants you to see, and avoid, the errors of his ways.
SBUX: 78.21 (+0.39), UA: 70.26 (-0.22), AMZN: 329.15 (+2.61), ESRX: 79.57 (+0.10), BBBY: 73.09 (+1.70), SNA: 135.42 (-0.36), DPZ: 93.05 (+1.64), WAG: 67.79 (unch), CL: 68.18 (-0.11)

Cramer's Mad Money - I Didn't Have Enough Confidence In Bed Bath & Beyond (11/19/14)
SA Editor Miriam Metzinger - Seeking Alpha - Thu Nov 20, 5:07AM CST
Stocks discussed on the in-depth session of Jim Cramer's Mad Money TV Program, Wednesday November 19. I Didn't Have Enough Confidence in Bed, Bath & Beyond (NASDAQ: BBBY ) . Other stocks mentioned: National Oilwell Varco (NYSE: NOV ),...
SBUX: 78.21 (+0.39), CBI: 55.02 (+0.62), NOV: 72.48 (+0.99), UA: 70.26 (-0.22), BBBY: 73.09 (+1.70), ESRX: 79.57 (+0.10), DPZ: 93.05 (+1.64), TKR: 42.41 (-0.04), WAG: 67.79 (unch), CL: 68.18 (-0.11)

11 Stocks Warren Buffett Loves in 2014
at The Street - Wed Nov 19, 7:28AM CST
Here's a look at 11 stocks Buffett's Berkshire Hathaway bought in the most recently reported quarter.
CHTR: 158.87 (+0.24), WMT: 84.48 (-0.51), PCP: 230.81 (-2.08), SU: 34.75 (+0.65), ESRX: 79.57 (+0.10), V: 250.65 (+0.79), IBM: 160.09 (-1.34), DTV: 87.14 (-0.08), GM: 32.07 (-0.08), LBRDK: 50.58 (-0.05), BRK.B: 145.35 (-0.30), VIAB: 73.73 (+0.25), BRK.A: 217,863.00 (-681.92), MA: 84.39 (+0.11)

Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Wed Nov 19, 3:40AM CST

MDLZ: 38.90 (-0.20), DNOW: 27.60 (+0.07), LMCK: 35.38 (-0.24), CHTR: 158.87 (+0.24), MTB: 123.95 (-0.67), WMT: 84.48 (-0.51), KRFT: 58.39 (+0.02), GHC: 869.88 (+1.88), PCP: 230.81 (-2.08), UPS: 105.47 (-0.17), NOV: 72.48 (+0.99), ESRX: 79.57 (+0.10), COST: 139.52 (-0.49), MA: 84.39 (+0.11), PSX: 77.23 (+1.46), TMK: 53.21 (-0.03), COP: 72.71 (+0.58), WFC: 53.27 (-0.09), MCO: 100.32 (-0.28), LMCA: 35.55 (-0.27), BRK.B: 145.35 (-0.30), BRK.A: 217,863.00 (-681.92), WBC: 103.12 (unch), LBTYK: 44.79 (-0.40), GE: 26.90 (-0.02), XOM: 95.66 (+0.05), SU: 34.75 (+0.65), JNJ: 107.76 (-1.00), T: 35.29 (-0.08), V: 250.65 (+0.79), LBTYA: 45.84 (-0.44), IBM: 160.09 (-1.34), DTV: 87.14 (-0.08), SNY: 46.68 (-1.41), BK: 39.75 (-0.04), KO: 44.27 (+0.05), CBI: 55.02 (+0.62), AXP: 90.49 (-0.01), LEE: 3.20 (+0.02), VRSN: 59.52 (+0.14), GS: 188.91 (-0.28), DVA: 74.91 (-0.21), VRSK: 62.13 (-0.08), MEG: 14.62 (+0.09), USB: 43.78 (-0.11), USG: 28.64 (+0.56), GM: 32.07 (-0.08), PG: 88.70 (-0.03), VIAB: 73.73 (+0.25), VZ: 50.21 (-0.28)

Express Scripts Sued in Scheme to Deny Pharmacy Payments for Compound Pharmaceuticals, according to Quadrino Law Group and The Simon Law Firm
Business Wire - Tue Nov 18, 12:53PM CST
Three pharmacies have sued Express Scripts, Inc. for violations of federal regulations in a scheme to deny payments for compound pharmaceuticals. The suit alleges that thousands of patients are being impacted by the scheme, according to Quadrino Law Group and The Simon Law Firm.
ESRX: 79.57 (+0.10)

Look for Shares of Express Scripts to Potentially Pullback after Yesterday's 1.54% Rise
Comtex SmarTrend(R) - Mon Nov 17, 4:44PM CST
Express Scripts (NASDAQ:ESRX) traded in a range yesterday that spanned from a low of $77.87 to a high of $79.12. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $78.22 on volume of 3.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ESRX: 79.57 (+0.10)

Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Express Scripts Is Up 4.6% (ESRX)
Comtex SmarTrend(R) - Mon Nov 17, 4:06PM CST
When Express Scripts (NASDAQ:ESRX) reported earnings 20 days ago on October 28th, 2014, analysts, on average, expected the company to report earnings of $1.29 on sales of $24.9 billion. Express Scripts actually reported earnings of $1.29 per share on sales of $25.8 billion, matching EPS estimates and beating revenue estimates by $880.0 million. Shares of Express Scripts have climbed from $74.41 to $77.87, representing a gain of 4.6% since the company reported earnings 20 days ago.
ESRX: 79.57 (+0.10)

Berkshire Likes Express Scripts- And So Do We
Morningstar - at Seeking Alpha - Mon Nov 17, 2:13PM CST
By Greggory Warren, CFA While wide-moat Berkshire Hathaway's (NYSE: BRK.B ) third-quarter 13-F filing was overshadowed this week by the firm's announcement that it would be exchanging its 52.8 million share stake in Procter & Gamble (NYSE: PG...
ESRX: 79.57 (+0.10), BRK.B: 145.35 (-0.30), BRK.A: 217,863.00 (-681.92)

Option Traders Bet on These Stocks to Break Out to New Highs
at The Street - Mon Nov 17, 4:45AM CST
An interesting trend emerged in the option market last week as traders bet on stocks to break out to new highs.
SPLS: 14.00 (+0.08), ESRX: 79.57 (+0.10), DNKN: 47.15 (+0.12), LGF: 34.77 (+0.24), AMAT: 22.64 (+0.05), RHT: 63.00 (+0.06), EMC: 30.10 (+0.17), NTAP: 42.01 (+0.20)

Warren Buffett Buys Express Scripts, But You Should Not
Stock Market Sherpa - at Seeking Alpha - Sat Nov 15, 8:55PM CST

ESRX: 79.57 (+0.10)

Tracking Glenn Greenberg's Brave Warrior Advisors Portfolio - Q3 2014 Update
John Vincent - at Seeking Alpha - Sat Nov 15, 10:45AM CST

KMI: 41.03 (+0.09), VRX: 142.84 (+0.37), HAL: 48.99 (+0.56), KMP: 100.21 (+0.45), BAC: 16.99 (-0.07), TDW: 37.53 (+0.34), VPRT: 67.60 (+0.80), ORCL: 40.97 (+0.05), PRI: 51.55 (+0.71), EPB: 43.18 (+0.26), ESRX: 79.57 (+0.10), EQIX: 224.11 (-1.57), JPM: 60.11 (-0.49), KMR: 101.35 (+0.34), MSFT: 48.14 (-0.08), CMCSA: 54.34 (-0.04), SCHW: 28.31 (-0.21)

Warren Buffett’s Berkshire Hathaway Sells Stake in John Deere and Buys More DirecTV Stock
Patrick Morris, The Motley Fool - Motley Fool - Sat Nov 15, 7:11AM CST
After the market closed today Warren Buffett's Berkshire Hathaway disclosed its latest stock holdings as of September 30, 2014 with the SEC. While the value of its portfolio was unchanged at $108 billion relative to the end of June and it...
ESRX: 79.57 (+0.10), CHTR: 158.97 (+0.34), DTV: 87.14 (-0.08), DE: 85.56 (-0.77), COP: 72.71 (+0.58)

Berkshire ups GM stake, exits Deere, buys into Express Scripts
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 3:28PM CST

ESRX: 79.57 (+0.10), DE: 85.56 (-0.77), GM: 32.07 (-0.08), BRK.B: 145.35 (-0.30), BRK.A: 217,863.00 (-681.92)

Scour Mutual Fund Special Sections For Great Ideas
at Investor's Business Daily - Wed Nov 12, 3:59PM CST
Institutional sponsorship is a key factor to check when researching stocks to buy. Why? Without demand from mutual funds, hedge funds and other big investors, which account for most of the market's daily activity, a stock cannot keep advancing....
GPRO: 74.61 (-4.48), ESRX: 79.57 (+0.10), WY: 34.21 (+0.01), MA: 84.39 (+0.11)

Express Scripts Earnings In Retrospect: Up 4.6% in the Last 13 Days (ESRX)
Comtex SmarTrend(R) - Mon Nov 10, 1:30PM CST
A week ago on October 28th, 2014 Express Scripts (NASDAQ:ESRX) reported earnings and analysts, on average, expected earnings of $1.29 on sales of $24.9 billion. Express Scripts actually reported earnings of $1.29 per share on sales of $25.8 billion, matching EPS estimates and beating revenue estimates by $880.0 million. Shares of Express Scripts have climbed from $74.41 to $77.87, representing a gain of 4.6% since the company reported earnings 13 days ago.
ESRX: 79.57 (+0.10)

Is CVS Health's "Tobacco-Tax" Brilliant or Stupid?
Todd Campbell, The Motley Fool - Motley Fool - Sun Nov 09, 8:44AM CST
Source: CVS Health Supporters are heralding CVS Health 's decision to create narrow pharmacy networks that penalize tobacco users as a brilliant move, but detractors think it may alienate customers. Both sides have valid arguments, but I...
ESRX: 79.57 (+0.10), CTRX: 49.16 (-0.22), MCK: 205.55 (-0.72), CVS: 89.44 (-0.15), WAG: 67.79 (unch), RAD: 5.56 (+0.04)

3 Things That Can Keep the Wind in Catamaran Corp.'s Sails
Keith Speights, The Motley Fool - Motley Fool - Sat Nov 08, 8:00AM CST
It's been a relatively rough year for Catamaran Corporation so far. Just a couple of weeks ago, the pharmacy benefits manager's stock was down more than 10% and even farther away from the highs seen in 2013. After a strong third-quarter earnings...
CI: 101.94 (-0.69), ESRX: 79.57 (+0.10), CTRX: 49.16 (-0.22), CVS: 89.44 (-0.15)

Why AbbVie Inc.'s Game-Changing New Drug Could Be a Serious Threat to Gilead Sciences Inc.
George Budwell, The Motley Fool - Motley Fool - Fri Nov 07, 7:45AM CST
The patent cliff might have decimated revenues in the world of Big Pharma, but it has also led to an unprecedented level of innovation within the industry.  In the coming years, for example, we should see four to five new types of drugs that are...
JNJ: 107.76 (-1.00), ESRX: 79.57 (+0.10), GILD: 102.20 (-0.14), ABBV: 65.24 (-0.26), BMY: 58.50 (-0.31), ENTA: 43.96 (+0.06)

Quarterly Financial Results, Study Results, and Appointments - Research Reports on Covidien, Community Health, Express Scripts, Caterpillar and Boeing
PR Newswire - Fri Nov 07, 7:35AM CST
Today, Analysts Review released its research reports regarding Covidien plc (NYSE: COV), Community Health Systems, Inc. (NYSE: CYH), Express Scripts Holding Company (NASDAQ: ESRX), Caterpillar Inc. (NYSE: CAT) and The Boeing Company (NYSE: BA). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7772-100free.
ESRX: 79.57 (+0.10), CYH: 46.79 (-0.66), COV: 96.94 (-0.56), CAT: 101.21 (-0.09), BA: 131.82 (+0.21)

Express Scripts Holding Company (ESRX) Stock Research Links

ESRX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Teachstone’s Bronze Award Puts Classroom Quality in Focus

Updated Category News Views 36

Small Classroom Moments Finally Get Their Due A child’s hesitant question can disappear in the noise of a busy classroom, which is precisely why Teachstone’s latest recognition deserves more than the usual polite golf clap. The Charlottesville-based Certified B Corporation received a Bronze Anthem Award for its “From Measurement to Momentum” initiative, in the...

Continue Reading
Cloud Security’s $26.8 Billion Test Is All About Execution

Updated Category News Views 65

A cloud dashboard that spits out ten thousand alerts is not protection; it is an expensive way to make a security team miserable. That frustration sits right in the middle of Frost & Sullivan’s projection that global cloud security revenue will climb from $8.4 billion in 2025 to $26.8 billion by 2031, a 21.4% compound annual growth rate. The number is hefty, no...

Continue Reading
Why Dent Repair Estimates Need More Than a Simple Ruler

Updated Category News Views 118

A dent can look harmless in a parking-lot glare and still turn into a stubborn repair job once somebody examines the metal properly. That is the useful, unglamorous point Jason Phelps of Magic Dent makes in a HelloNation article: visible diameter is not a verdict. Anybody shopping for vehicle repairs, managing fleet costs, or watching the collision-service ecosystem ought...

Continue Reading
San Bernardino Teamsters Back Their Historic Contract

Updated Category News Views 86

A 90% vote does not whisper; it rattles the filing cabinets. More than 12,000 San Bernardino County members of Teamsters Local 1932 have ratified a new labor agreement with over 90% approval, according to the union’s November 20 announcement. In a public-sector negotiation, that kind of margin matters because it tells management the workforce is not merely accepting a...

Continue Reading
GIGABYTE Pitches Local AI Agents to Enterprise Buyers

Updated Category News Views 72

Enterprise AI has reached the awkward stage where a slick chatbot demo no longer cuts it. GIGABYTE used its November 13 AI Partner Summit at the Pacific Palms Resort to make a more grounded pitch: companies need hardware and software setups that can put AI agents to work without casually tossing proprietary information into somebody else’s cloud. That is a sensible...

Continue Reading
Label-Free Detection Has a Solid, Narrow Growth Lane

Updated Category News Views 133

Biologics labs are turning into a far better hunting ground for analytical equipment than the old, broad-brush research story suggests. Label-free detection is not a giant market, and nobody should dress it up as one. But the projected move from $0.58 billion in 2026 to $0.85 billion by 2031 points to a useful 8.1% annual growth lane, driven by work researchers genuinely...

Continue Reading
Travel Disruptions Reveal the Value of Human Support

Updated Category News Views 95

Air travel’s ugly little secret surfaced again during the recent ground stop: a reservation is easy, but rescuing a trip is labor-intensive, fast-moving work. Internova Travel Group says its people across Travel Leaders Network, Global Travel Collection and ALTOUR moved quickly as cancellations piled up and travelers were left staring at busted itineraries. That is not...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 121

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Neurelis Founder Earns EY's 2026 Top Entrepreneur Honor

Updated Category News Views 95

Some business awards are wallpaper; this one carries real clinical weight. EY US named Craig Chambliss, CEO and co-founder of Neurelis, its Entrepreneur Of The Year 2026 National Overall Award winner. In a sector where plenty of companies talk grandly about changing lives and then vanish into the regulatory fog, the underlying story matters more than the trophy. Neurelis...

Continue Reading
Alabama Power's 2027 Cut Puts Data Centers to Work

Updated Category News Views 87

Data centers rarely arrive bearing a gift for ordinary power customers. Yet Alabama Power says its coming load growth will help cut customer rates by $160 million in 2027, beginning with January bills. In a utility world stuffed with requests for more money, that is a sharp change of pace. The company filed the reduction with the Alabama Public Service Commission on Nov....

Continue Reading

Top 5 Most Recently Viewed Articles

American Teachers Alliance Initiates Empowering Programs for Students

Updated Category News Views 143

Empowering Future Educators with College Chapters In a progressive move to inspire and support the upcoming generation of teachers, the American Teachers Alliance (ATA) has launched a significant initiative aimed at engaging college students across universities. This initiative introduces college student chapters, fostering a community where aspiring educators can enhance...

Continue Reading
Enhancing Enterprise Collaboration: Progress ShareFile and Microsoft 365

Updated Category News Views 190

Introduction to Progress ShareFile's New Features Progress, a leading provider of AI-driven digital experience and infrastructure software, is excited to announce significant advancements to its ShareFile platform. The recent updates mark a transformative leap in how enterprises collaborate using Microsoft 365, empowering teams to work more securely and efficiently. Deep...

Continue Reading
Shareholder Alert: Investigations on Major Mergers for 2025

Updated Category News Views 314

Investigating Significant Mergers in 2025 In the financial landscape, the merging of companies can significantly impact shareholders. Recognizing the importance of every shareholder's voice, we delve into several notable mergers that are under scrutiny as we approach votes critical to shareholders. As many companies opt for merger routes, understanding the implications of...

Continue Reading
Explore the Vibrant Daylight Shows Series in NYC's Hotspots

Updated Category News Views 181

Unveiling the Daylight Shows at Daylight Studio Experience the vibrant world of creativity at Daylight Studio, a prominent event venue nestled in two of New York City's most dynamic areas, Hudson Yards and Flatiron. With years of experience in supporting film, fashion, and artistic endeavors, Daylight Studio has secured its place as a go-to location for creatives and...

Continue Reading
Ventyx Biosciences Begins Phase 2a Trial for Parkinson’s Treatment

Updated Category News Views 138

Ventyx Biosciences Begins Phase 2a Trial for VTX3232 Ventyx Biosciences, Inc. (Nasdaq: VTYX), a company focused on creating innovative oral treatments for various inflammatory diseases, has announced the start of dosing for its Phase 2a clinical trial of VTX3232. This important trial is centered on individuals who have been diagnosed with the early stages of Parkinson’s...

Continue Reading